Navigation Links
Survival Data for Avicena's Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
Date:10/18/2007

ompromised. With an incidence rate of approximately 1 in 10,000, ALS affects roughly 30,000 Americans at any given time. Each year, approximately 5,600 new cases of ALS are diagnosed. The two types of ALS are "sporadic ALS," which accounts for approximately 85% - 90% of all cases; and "familial ALS," which accounts for the remaining 10% - 15% of patients. A progressive degeneration of motor neurons eventually leads to neuron death resulting in the brain's inability to initiate or control muscle movement. Once a patient's muscles no longer receive the messages that they require to function, muscles begin to atrophy.

ABOUT AVICENA

Avicena Group, Inc. (OTC Bulletin Board: AVGO) is a Palo Alto, California based late-stage biotechnology company that develops central nervous system therapeutics for neurodegenerative diseases. The Company's core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena's pharmaceutical program centers on rare neurological disorders (orphan diseases). Near term, the Company plans to initiate a confirmatory Phase III trial in ALS and a Phase III trial in Huntington's disease to accompany the ongoing NIH Phase III trial in Parkinson's disease. Avicena's science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena's clinical programs are largely funded by government and non-profit organizations. Avicena presently derives revenue from the sale of proprietary dermaceutical ingredients to skin care manufacturers.

SAFE HARBOR

This release contains forward-looking statements that reflect, among other things, management's current expectations, plans and strategies, all of which are subject to known and unknown risks, uncertainties and factors that may cause our actual results to differ materially from those expressed or implied by these forward-looking statements. Many of these risks are beyond
'/>"/>

SOURCE Avicena Group, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
2. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
3. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
4. Velcade (bortezomib) for Injection Based Therapies Achieved Survival Rates as High as 100 Percent in Newly Diagnosed Multiple Myeloma Patients
5. Velcade (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
10. Synta Presents Results for STA-4783 in Metastatic Melanoma Showing Improvement in Overall Survival
11. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2014)... VIENNA , September 3, 2014 /PRNewswire/ ...   to be located in the ... Nabriva Therapeutics AG, a biotechnology company ... antibiotics for the treatment of serious infections caused by ... Broom as Chief Executive Officer (CEO). Current CEO Ralf Schmid will ...
(Date:9/3/2014)... ,    ~ Clinical ... Kiadis Pharma B.V. ("Kiadis Pharma", ... developing T-cell immunotherapy treatments for blood cancers, today announces ... PhD, as its Chief Medical Officer. Jeroen ... Biosciences. Prior to that he was VP Medical Affairs ...
(Date:9/3/2014)... BUDAPEST, Hungary , Sept. 3, 2014 /PRNewswire/ ... "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") announced ... license agreement to co-develop and commercialize bremelanotide for ... Union, other European countries and additional selected countries.  ... a strong focus in female health and annual ...
Breaking Medicine Technology:Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 2Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 3Nabriva Therapeutics Appoints Dr Colin Broom as Chief Executive Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 2Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 3Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 4Kiadis Pharma Appoints Jeroen Rovers as its Chief Medical Officer 5Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 2Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 3Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 4Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter 5
... Sigma-Aldrich Corporation (NASDAQ: SIAL ) will ... KeyBanc Capital Markets 2011 Basic Materials ... InterContinental, Boston, MA, presenting at 9:00 AM (Eastern). ... at the Grand Hyatt, New York, NY, presenting at ...
... SimonMed and Cox Business have partnered to make a ... patients in the Valley and across the state at ... is the first dedicated outpatient offering of breast tomosynthesis ... in Scottsdale. Sub-specialty trained radiologists at SimonMed ...
Cached Medicine Technology:Sigma-Aldrich Corporation to Present at Upcoming Investor Conferences 2SimonMed and Cox Business Bring Breast Tomosynthesis to Arizona 2
(Date:9/3/2014)... Angeles, CA (PRWEB) September 03, 2014 ... is hosting a free webinar called “Google Hates ... the live presentation will reveal common problems that render ... – and offer strategies to overcome them. , The ... 10th, beginning at 11am PST (2 pm EST), and ...
(Date:9/3/2014)... Viejo, California (PRWEB) September 03, 2014 ... new ProStatic Lesson from Pixel Film Studios. , “ProStatic ... TV and VCR static to special effect artist,” said ... users customizable options to create the static distortion based ... static effects of an old television or VCR in ...
(Date:9/3/2014)... (PRWEB) September 03, 2014 Londi Palmisano, ... to offer an innovative solution for people looking for ... muscles of the back and upper body. In a ... really innovative and functional design for promoting increased flexibility ... body weight, and a gentle rocking motion. , Then, ...
(Date:9/3/2014)... Mila Carlson, PhD, RN, CLNC, CNLCP, ... healthcare provider. Celebrating 5 years of successful service ... of the National Alliance of Certified Legal ... Consultants, American Association of Legal Nurse Consultants-Greater Chicago ... Care Planners. , Dr. Carlson’s background is ...
(Date:9/3/2014)... Seattle, Wa (PRWEB) September 03, 2014 ... report created by Nguyen Do on the site Vkool.com, ... on health and beauty, and provides detailed instructions on ... of this report, people will discover some reasons to ... soothes chapped lips ,     It may protect against ...
Breaking Medicine News(10 mins):Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 2Health News:Fred Joyal Webinar Warns Dentists: Google Hates Your Website 3Health News:A New ProStatic Lesson was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Body Archer's Solution for Perfect Back Stretching Sparks Interest Among Health Care Pros 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 2Health News:Mila Carlson & Associates, P.C., Celebrates 5 Years of Excellence in Business Serving as a Legal Nurse Consultant and Nurse Life Care Planner 3Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 2Health News:“Health And Beauty Benefits Of Olive Oil,” a New Report on Vkool.com, Reveals to People the Benefits of Olive Oil on Health and Beauty 3
... found the survival rate of non-small-cell lung cancer ... adjuvant chemotherapy. Cisplatin is an anti-neoplastic medication that ... slows their growth and spread in the body. ... receive either three or four cycles of cisplatin-based ...
... the world's first epilepsy drug, an Australian neurologist says.// ... a mild sedative, taken either as a herbal infusion ... form. ,But the Italian author Fabio Colonna first ... botanical work Phytobasanos. ,Colonna said he had controlled ...
... dads who have children at an older age may ... in life. ,Researchers based their analysis on ... between 1989 and 2001 with a diagnosis of schizophrenia ... strong association between the fathers' age at conception and ...
... use stomach-acid suppressive medications for indigestion or gastroesophageal reflux ... of developing pneumonia .// ,The use of ... infections, as stomach acidity is a major defense mechanism ... than 364,000 patients who did and did not use ...
... say they have found that the drug toremifene, also ... decreased patients' cancer incidence after 12 months of treatment. ... but the 20-milligram dose had the greatest effect. ... neoplasia, characterized by abnormal cells in the lining of ...
... that sleep disorders may be linked to other medical ... neuromuscular conditions, and psychiatric problems. ,Researchers conducted a ... apnea also had ADD. Results also show a high ... showed some of these patients also suffered severe memory ...
Cached Medicine News:Health News:Valerian was first epilepsy drug 2
Double ended lasik spatula with flattened tip for lifting and smoothing the corneal flap. The sharp tip is useful to outline a previous flap in preparation for retreatment....
Rounded tip spatula with 20 gauge shaft. Black finish for reduced glare....
Triangular 0.5 mm angled tip with 4 mm flat surface. Round knurled handle with dull finish. Tip angle: 150o....
Double ended with 0.5 mm x 10 mm and 0.5 mm x 15 mm blades. Both blades gently curved. Square serrated handle with polished finish. Most popular size or model....
Medicine Products: